NDC 36987-1782

Fire Ant

Fire Ant

Fire Ant is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Solenopsis Invicta.

Product ID36987-1782_0dfdf82e-c929-42cd-8393-5392bfe2ea7c
NDC36987-1782
Product TypeHuman Prescription Drug
Proprietary NameFire Ant
Generic NameFire Ant
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1972-08-29
Marketing CategoryBLA / BLA
Application NumberBLA102192
Labeler NameNelco Laboratories, Inc.
Substance NameSOLENOPSIS INVICTA
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Insect Venom Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [CS],Ant Venoms [CS],Allergens [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 36987-1782-4

50 mL in 1 VIAL, MULTI-DOSE (36987-1782-4)
Marketing Start Date1972-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36987-1782-3 [36987178203]

Fire Ant INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-1782-4 [36987178204]

Fire Ant INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-1782-1 [36987178201]

Fire Ant INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-1782-2 [36987178202]

Fire Ant INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
SOLENOPSIS INVICTA.05 g/mL

OpenFDA Data

SPL SET ID:33f34062-9219-458c-bb25-7f469a08cd6d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 905099
  • 905279
  • 905261
  • 968004
  • 967924

    • Pharmacological Class

    • Non-Standardized Insect Venom Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Insect Proteins [CS]
    • Ant Venoms [CS]
    • Allergens [CS]

    NDC Crossover Matching brand name "Fire Ant" or generic name "Fire Ant"

    NDCBrand NameGeneric Name
    0268-0722FIRE ANTSOLENOPSIS INVICTA
    0268-0724FIRE ANTSOLENOPSIS INVICTA
    22840-1003Fire AntSolenopsis invicta
    22840-1005Fire AntSolenopsis richteri
    22840-1023Fire AntSolenopsis invicta
    22840-5001Fire AntSolenopsis invicta
    22840-5002Fire AntSolenopsis richteri
    36987-1778Fire AntFire Ant
    36987-1779Fire AntFire Ant
    36987-1780Fire AntFire Ant
    36987-1781Fire AntFire Ant
    36987-1782Fire AntFire Ant
    36987-1785Fire AntFire Ant
    36987-1783Fire AntFire Ant
    36987-1784Fire AntFire Ant
    54575-315FIRE ANTFIRE ANT
    0268-6400SOLENOPSIS INVICTAFire Ant
    0268-6401SOLENOPSIS INVICTAFire Ant
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.